Latest other current liabilities for SHUKRAPHAR.BO: $200M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Shukra Pharmaceuticals Limited (SHUKRAPHAR.BO) currently reports a other current liabilities of $200M as of September 2026. That compares with $81M in the prior-year period — up 147.8% year over year. Use the charts on this page to explore Shukra Pharmaceuticals Limited's other current liabilities history and peer comparisons.
Shukra Pharmaceuticals Limited's other current liabilities increased from $81M to $200M — a 147.8% year-over-year increase (period ending September 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Shukra Pharmaceuticals Limited reported $200M in other current liabilities as of September 2026. That compares with $81M in the prior-year period — up 147.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current other current liabilities of $200M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Shukra Pharmaceuticals Limited, and consider following SHUKRAPHAR.BO for alerts when major investors trade the stock.